The ongoing enigma of SARS‐CoV‐2 and platelet interaction
Abstract Since the onset of the global pandemic of coronavirus disease 2019 (COVID‐19), there is an urgent need to understand the pathogenesis of the common inflammatory and thrombotic complications associated with this illness leading to multiorgan failure and mortality. It is well established that...
Main Authors: | Younes Zaid, Fadila Guessous |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12642 |
Similar Items
-
Platelet Count in Patients with SARS-CoV-2 Infection: A Prognostic Factor in COVID-19
by: Andrea Boccatonda, et al.
Published: (2022-07-01) -
The Ways of the Virus: Interactions of Platelets and Red Blood Cells with SARS-CoV-2, and Their Potential Pathophysiological Significance in COVID-19
by: Mikhail A. Panteleev, et al.
Published: (2023-12-01) -
SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism
by: Shu Shen, et al.
Published: (2021-04-01) -
Recombinant ACE2 Expression Is Required for SARS-CoV-2 To Infect Primary Human Endothelial Cells and Induce Inflammatory and Procoagulative Responses
by: Jonas Nascimento Conde, et al.
Published: (2020-12-01) -
Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
by: Sai Priya Anand, et al.
Published: (2020-09-01)